Close Menu

NEW YORK (GenomeWeb) ­– Memorial Sloan Kettering Cancer Center said today that New York state has approved the center's liquid biopsy test for noninvasive cancer genomic profiling and disease monitoring.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.